Digitize Regulatory Compliance in Your Healthcare Facility

Posted on by

Surglogs is the first software company to offer a full suite of automated regulatory compliance solutions for healthcare facilities like hospitals and ambulatory surgery centers. It is designed to improve the everyday routines of clinicians by replacing the time and labor-intensive pen-and-paper documentation process with an easy-to-navigate digital platform.

The platform features mobile and desktop applications that can be accessed from anywhere with an Internet connection, enabling clinicians to gather real-time data on the facility’s regulatory compliance. This includes all accreditation logs, biomedical logs, scheduled drugs, life & fire safety, credentialing, vendor contracts and much more.

The Surglogs compliance suite is customized to the facility’s needs and securely houses the entire database of logs in a HIPAA compliant, encrypted cloud. Surglogs has saved thousands of dollars in labor and storage costs for healthcare facilities across the United States through improving clinical compliance calculations as well as providing clinicians with peace of mind for their future accreditation and state surveys.

Surglogs representatives work alongside clinical leadership to tailor these modules to fit the specific compliance requirements of their facility. Surglogs compliance suite not only adds time back into a clinician’s routine but also greatly reduces the cost of running a facility when compared to the labor and storage costs expended for pen-and-paper documentation.

Users can access their custom Surglogs dashboard through the desktop portal. The Surglogs mobile application allows clinicians to see the exact same information no matter their location, which frees them up for continued education, QAPI’s or even free time with their family.

Get Your 30-day Free Trial
Posted in ,

Let’s Talk About Depression

Posted on by
Today is the World Health Day; for this year, the WHO strives to raise awareness of depression and has put together a campaign with very useful material to be shared with patients. More than 300 million people of all ages suffer from depression, which is the leading cause of disability worldwide, and a major contributor to the overall global burden of disease.
We invite you to join us on Among Doctors and discuss best practices & experiences on #depression and #mentalhealth in our dedicated group.
 
Image credit: WHO
Posted in , , , ,

Colorectal Cancer Incidence in a Dramatic Increase in the US

Posted on by

A study published by the American Cancer Society found a steep increase in the rate of colorectal cancer rose in adults younger than age 55 years. Three in 10 colorectal cancer diagnoses occur in people of this age group. The authors call for considering early screening as the proportion of rectal cancer diagnosed in adults younger than age 55 years years has doubled in just two decades.

What do you think? Discuss the news on Among Doctors: https://network.amongdoctors.com/userpanel/sharepost/846

Posted in , , , ,

What Is the Impact of the Doctor’s Gender?

Posted on by

In a recent paper published in JAMA Internal Medicine, the authors reported that patients treated by female physicians had significantly lower mortality and readmission rates compared with those cared for by male physicians. Even though the study did not provide the reasons of such a difference, the authors noted previous evidence suggesting that female physicians would be more likely to provide patient-centred care, psychosocial counselling, and evidence-based medicine, while their male colleagues would be less cautious when managing more complicated patients.

What do you think? Join our discussion on Among Doctors!

Posted in , ,

Artificial Intelligence Achieves Dermatologist-Level Skin Cancer Classification

Posted on by

A team of researchers from the Stanford’s Artificial Intelligence Laboratory employed a deep learning algorithm developed by Google (GoogleNet Inception v3 CNN architecture) to create an automated system for the classification of skin cancer. The algorithm that was already able to recognise objects from 1.28 million images, was trained using nearly 130,000 clinical images of more than 2,000 diseases. In a paper published on Nature, the researchers described how they employed over 370 biopsy-confirmed images to assess the artificial intelligence performance against 21 board-certified dermatologists. Notably, the algorithm matched the sensitivity and specificity of the experts’ opinion in classifying correctly keratinocyte carcinomas, melanomas classification and benign lesions. The new system paves the way of accessible and cost-effective applications that will enable recognition of skin lesions with the use of such devices as smartphones.

What is your opinion? Discuss on Among Doctors!

Image Credit: Stanford/Matt Young

Posted in , , , , ,

Study finds 33% of adults recently diagnosed with asthma do not have it

Posted on by

A new study from the Ottawa Hospital Research Institute, which was published in the Journal of the American Medical Association, found that 33% of adults recently diagnosed with asthma did not have it. Over 90% of them were able to stop their asthma medications.

What is your opinion? Discuss on Among Doctors: https://network.amongdoctors.com/userpanel/sharepost/824

Posted in ,

The World Is Getting Fatter

Posted on by

Based on a study published on The Lancet, blogger Max Galka created this animated map to illustrate the skyrocketing worldwide increase in obesity from 1975 to 2014. According to the study, in the last 40 years, obesity rates increased from 3.2% to 10.8% for men, and from 6.4% to 14.9% for women. Overall, there were 105 million obese people in 1975; that number rose to 641 million in 2014, with China and US being the leading nations with approximately 90 and 87 million obese people respectively.

What do you think? What are the consequences and how can we tackle this worldwide epidemic? Discuss & share more news on Among Doctors:
https://network.amongdoctors.com/userpanel/sharepost/793

Image credit: Metrocosm.com

Posted in , , ,

Prevalence of Dementia in the United States in 2000 and 2012

Posted on by

In a large cohort study of more than 21,000 adults 65 years or older in the US, the authors reported that the prevalence of dementia decreased significantly from 11.6% to 8.8% between 2000 and 2012. Notably, an increasing educational attainment may have contributed to such an improvement.

Read more and discuss on Among Doctors: https://network.amongdoctors.com/userpanel/sharepost/776

Posted in ,

28th July: World Hepatitis Day

Posted on by

On this year’s World Hepatitis Day, WHO calls for a rapid action to raise awareness of the disease, and increase access to testing and treatment services. Globally, 400 million people are affected by a viral hepatitis infection -a number that represents more than 10 times that of people infected with HIV. According to WHO, it is estimated that approximately 95% of people with chronic hepatitis are unaware of their infection, and less that 1% have access to treatment.

Moreover, WHO has recently published guidelines for the screening and treatment of people with hepatitis C infection, providing recommendations on the preferred regimens, and encouraging the employment of direct-acting antiviral combinations when appropriate.

Comment the story on Among Doctors!

Posted in , ,

New recommendations on antiretroviral drugs for HIV infection

Posted on by

The International Antiviral Society – USA Panel published their updated recommendations on antiretroviral drugs (ARVs) for the treatment and prevention of HIV infection. With more than 37 million people living with an HIV infection in the world, and 20 million not receiving an antiretroviral therapy, the new guidelines reiterate that all individuals diagnosed with the infection should initiate treatment as soon as possible, regardless of the CD4 cell count.

Moreover, the guidelines reflect on the substantial advances of the ARVs since the last recommendations were released in 2014, recommending initial regimens of two nucleoside reverse transcriptase inhibitors (NRTIs) plus an integrase strand transfer inhibitor (InSTI) for most patients. Further points on preexposure and postexposure prophylaxis are discussed, as well as the pharmacoeconomics of the treatment, especially considering the introduction of less-expensive generic formulations.

In the accompanying editorial on JAMA, Kenneth Mayer and Douglas Krakower consider the guidelines a reflection of a successful 35-year research effort and argue that, “Historians may wonder whether the pace of discovery in the early days of the epidemic could have been accelerated, but no one can doubt the signal accomplishments of biobehavioral research and community engagement in forging a common strategy to deal with this global pandemic, one that continues to pose new challenges.”

Comment the story on Among Doctors!

Posted in , ,